I can't argue at all with the feedback you have provided. All true.
I do find the stock very interesting with Hunter Hall buying in strongly (it felt like they were the only buyer for months) and Wentworth Williamson who are a deep value fund. Clearly both of these insto's have done their research and they would want to succeed because they are going to have extreme problems exiting in volume if they are wrong.
I'm assuming they are selling the Karratha rental business which they will use to soften the blow over an earnings downrade. As mentioned before it's highly likely the problems with Bloomer were going to take over 6 months to fix and they would have bled some coin. Amazing they were QLD's biggest builder at one stage, OTR buys them and they have been a disaster (to date).
With Meadowbrook delayed McGrath might have leaked a bit of coin, but expect it will be back on track when this contract kicks in (which should be shortly).
Couran Cove looks great at this stage, but so did the Bloomer acquisition at the time.
There's potential here, but it could go either way. Share price wise i'm expecting a whack when it comes out of the trading halt.
- Forums
- ASX - By Stock
- OTR
- Why No?
Why No?, page-13
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OTR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online